Table 2.
Categorization of eligible patients as T2DM and non-DM subjects
Data source | TPs, N | FPs, N | TNs, N | FNs, N | Sensitivity (TP/(TP+FN)),% | Specificity (TN/(FP+TN)), % | PPV (TP/(TP+FP)), % | FNR (FN/(TP+FN)), % | p Value* |
T2DM subject | |||||||||
Mayo Clinic alone | 513 | 27 | 11 948 | 252 | 67.1 | 99.8 | 95.0 | 32.9 | <0.001 |
Mayo Clinic + OMC | 765 | 0 | 11 975 | 0 | 100 | 100 | 100 | 0 | |
Non-DM subject | |||||||||
Mayo Clinic alone | 2683 | 215 | 8269 | 1573 | 63.0 | 97.5 | 92.6 | 37.0 | <0.001 |
Mayo Clinic + OMC | 4256 | 0 | 8484 | 0 | 100 | 100 | 100 | 0 |
p Value for comparison of categorizations between Mayo Clinic alone and Mayo Clinic + OMC.
DM, diabetes mellitus; FNR, false-negative rate; FN, false negative; FP, false positive; OMC, Olmsted Medical Center; PPV, positive predictive value; TN, true negative; TP, true positive; T2DM, type 2 diabetes mellitus.